HomeCompareFRES vs CL

FRES vs CL: Dividend Comparison 2026

FRES yields 235.29% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRES wins by $315.57M in total portfolio value
10 years
FRES
FRES
● Live price
235.29%
Share price
$0.85
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$315.61M
Annual income
$171,899,209.13
Full FRES calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — FRES vs CL

📍 FRES pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRESCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRES + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRES pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRES
Annual income on $10K today (after 15% tax)
$20,000.00/yr
After 10yr DRIP, annual income (after tax)
$146,114,327.76/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, FRES beats the other by $146,109,736.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRES + CL for your $10,000?

FRES: 50%CL: 50%
100% CL50/50100% FRES
Portfolio after 10yr
$157.83M
Annual income
$85,952,305.55/yr
Blended yield
54.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

FRES
Analyst Ratings
1
Buy
Consensus: Buy
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRES buys
0
CL buys
0
No recent congressional trades found for FRES or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRESCL
Forward yield235.29%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$315.61M$40.8K
Annual income after 10y$171,899,209.13$5,401.96
Total dividends collected$299.93M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: FRES vs CL ($10,000, DRIP)

YearFRES PortfolioFRES Income/yrCL PortfolioCL Income/yrGap
1← crossover$34,229$23,529.41$11,012$312.01+$23.2KFRES
2$111,896$75,270.83$12,196$412.95+$99.7KFRES
3$349,693$229,963.68$13,599$549.66+$336.1KFRES
4$1,045,826$671,655.14$15,288$736.64+$1.03MFRES
5$2,996,342$1,877,308.05$17,353$995.28+$2.98MFRES
6$8,232,794$5,026,707.34$19,926$1,357.80+$8.21MFRES
7$21,716,990$12,907,901.09$23,194$1,873.82+$21.69MFRES
8$55,058,944$31,821,764.79$27,439$2,621.52+$55.03MFRES
9$134,312,616$75,399,545.57$33,088$3,727.38+$134.28MFRES
10$315,613,708$171,899,209.13$40,806$5,401.96+$315.57MFRES

FRES vs CL: Complete Analysis 2026

FRESStock

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Full FRES Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this FRES vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRES vs SCHDFRES vs JEPIFRES vs OFRES vs KOFRES vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.